A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

December 31, 2012

Conditions
Methicillin Resistant Staphylococcus Aureus Skin Infections
Interventions
DRUG

mupirocin and chlorhexidine

"Mupirocin (Bactroban Nasal): twice a day for 7 days, apply one pea-sized amount of Bactroban Nasal ointment directly into one nostril and another pea-sized amount for the other nostril.~Chlorhexidine (Hibiclens): once a day for 14 days, rinse body with chlorhexidine."

BEHAVIORAL

household cleaning and disinfection

Environmental cleaning with topical ethanol and laundering of clothes and linen.

DRUG

mupirocin, chlorhexidine, & household cleaning/disinfection

"Mupirocin (Bactroban Nasal): twice a day for 7 days, apply one pea-sized amount of Bactroban Nasal ointment directly into one nostril and another pea-sized amount for the other nostril.~Chlorhexidine (Hibiclens): once a day for 14 days, rinse body with chlorhexidine.~Environmental cleaning with topical ethanol and laundering of clothes and linen."

Trial Locations (6)

90034

Kaiser Permanente, West LA, West Los Angeles

90706

Kaiser Permanente, Bellflower, Bellflower

90710

Kaiser Permanente, Harbor City, Harbor City

91402

Kaiser Permanente, Panorama City, Panorama City

92618

Kaiser Permanente, Irvine, Irvine

92807

Kaiser Permanente, Anaheim, Anaheim

All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

lead

loren g miller

OTHER

NCT00560599 - A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection | Biotech Hunter | Biotech Hunter